QUALCOMM INC/DE, 10-Q filed on 1/31/2024
Quarterly Report
v3.24.0.1
Cover Page - shares
shares in Millions
3 Months Ended
Dec. 24, 2023
Jan. 29, 2024
Cover [Abstract]    
Entity Registrant Name QUALCOMM INC/DE  
Entity Central Index Key 0000804328  
Document Fiscal Year Focus 2024  
Document Fiscal Period Focus Q1  
Amendment Flag false  
Current Fiscal Year End Date --09-29  
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Dec. 24, 2023  
Document Transition Report false  
Entity File Number 0-19528  
Entity Registrant State of Incorporation DE  
Entity Employer ID 95-3685934  
Entity Address 5775 Morehouse Dr.  
Entity City San Diego  
Entity State CA  
Entity Zip Code 92121-1714  
City Area Code (858)  
Entity Phone Number 587-1121  
Title of 12(b) Security Common Stock, $0.0001 par value  
Trading Symbol QCOM  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   1,116
v3.24.0.1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
shares in Millions, $ in Millions
Dec. 24, 2023
Sep. 24, 2023
Current assets:    
Cash and cash equivalents $ 8,133 $ 8,450
Marketable securities 3,921 2,874
Accounts receivable, net 3,513 3,183
Inventories 6,247 6,422
Held for sale assets 337 341
Other current assets 1,288 1,194
Total current assets 23,439 22,464
Deferred tax assets 3,579 3,310
Property, plant and equipment, net 4,907 5,042
Goodwill 10,722 10,642
Other intangible assets, net 1,387 1,408
Held for sale assets 69 88
Other assets 8,032 8,086
Total assets 52,135 51,040
Current liabilities:    
Trade accounts payable 2,147 1,912
Payroll and other benefits related liabilities 1,757 1,685
Unearned revenues 210 293
Short-term debt 914 914
Held for sale liabilities 336 333
Other current liabilities 3,805 4,491
Total current liabilities 9,169 9,628
Unearned revenues 93 99
Income taxes payable 1,056 1,080
Long-term debt 14,566 14,484
Held for sale liabilities 43 38
Other liabilities 4,150 4,130
Total liabilities 29,077 29,459
Commitments and contingencies (Note 5)
Stockholders’ equity:    
Preferred stock, $0.0001 par value; 8 shares authorized; none outstanding $ 0 $ 0
Preferred stock, par value $ 0.0001 $ 0.0001
Preferred stock, shares authorized 8 8
Preferred stock, shares outstanding 0 0
Common stock and paid-in capital, $0.0001 par value; 6,000 shares authorized; 1,118 and 1,114 shares issued and outstanding, respectively $ 0 $ 490
Common stock, par value $ 0.0001 $ 0.0001
Common stock, shares authorized 6,000 6,000
Common stock, shares, issued 1,118 1,114
Common stock, shares, outstanding 1,118 1,114
Retained earnings $ 22,565 $ 20,733
Accumulated other comprehensive income 493 358
Total stockholders’ equity 23,058 21,581
Total liabilities and stockholders’ equity $ 52,135 $ 51,040
v3.24.0.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Millions, $ in Millions
3 Months Ended
Dec. 24, 2023
Dec. 25, 2022
Revenues:    
Equipment and services $ 8,316 $ 7,784
Licensing 1,619 1,679
Total revenues 9,935 9,463
Costs and expenses:    
Cost of revenues 4,312 4,044
Research and development 2,096 2,251
Selling, general and administrative 627 623
Other (28) 80
Total costs and expenses 7,007 6,998
Operating income 2,928 2,465
Interest expense (178) (170)
Investment and other income, net 212 76
Income from continuing operations before income taxes 2,962 2,371
Income tax expense (151) (98)
Income from continuing operations 2,811 2,273
Discontinued operations, net of income taxes (44) (38)
Net income $ 2,767 $ 2,235
Basic earnings per share, Continuing operations $ 2.52 $ 2.02
Basic loss per share, Discontinued operations (0.04) (0.03)
Basic earnings per share 2.48 1.99
Diluted earnings per share, Continuing operations 2.50 2.01
Diluted loss per share, Discontinued operations (0.04) (0.03)
Diluted earnings per share $ 2.46 $ 1.98
Shares used in per share calculations:    
Basic 1,116 1,122
Diluted 1,127 1,131
v3.24.0.1
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)
$ in Millions
3 Months Ended
Dec. 24, 2023
Dec. 25, 2022
Statement of Comprehensive Income [Abstract]    
Net income $ 2,767 $ 2,235
Other comprehensive income, net of income taxes:    
Foreign currency translation gains 83 162
Net unrealized gains on available-for-sale debt securities 32 14
Net unrealized gains on derivative instruments 17 119
Other gains 1 0
Other reclassifications included in net income 2 20
Total other comprehensive income 135 315
Comprehensive income $ 2,902 $ 2,550
v3.24.0.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
3 Months Ended
Dec. 24, 2023
Dec. 25, 2022
Operating Activities:    
Net income from continuing operations $ 2,811 $ 2,273
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization expense 437 398
Income tax provision less than income tax payments (1,012) (120)
Share-based compensation expense 602 634
Net gains on marketable securities and other investments (71) (25)
Other items, net 9 (33)
Changes in assets and liabilities:    
Accounts receivable, net (325) 1,694
Inventories 165 (476)
Other assets 115 409
Trade accounts payable 241 (1,264)
Payroll, benefits and other liabilities 74 (286)
Unearned revenues (81) (81)
Net cash used by operating activities from discontinued operations (16) (28)
Net cash provided by operating activities 2,949 3,095
Investing Activities:    
Capital expenditures (214) (398)
Purchases of debt and equity marketable securities (1,452) (22)
Proceeds from sales and maturities of debt and equity marketable securities 463 219
Acquisitions and other investments, net of cash acquired (60) (29)
Proceeds from sales of property, plant and equipment 5 111
Other items, net 2 (14)
Net cash used by investing activities (1,256) (133)
Financing Activities:    
Proceeds from short-term debt 400 1,458
Repayment of short-term debt (400) (1,955)
Proceeds from long-term debt 0 1,880
Repurchases and retirements of common stock (784) (1,270)
Dividends paid (895) (842)
Payments of tax withholdings related to vesting of share-based awards (370) (309)
Other items, net 8 23
Net cash used by financing activities (2,041) (1,015)
Effect of exchange rate changes on cash and cash equivalents 15 27
Net (decrease) increase in total cash and cash equivalents (333) 1,974
Total cash and cash equivalents at beginning of period (including $77 and $326 classified as held for sale at September 24, 2023 and September 25, 2022, respectively) 8,527 3,099
Total cash and cash equivalents at end of period (including $61 and $265 classified as held for sale at December 24, 2023 and December 25, 2022, respectively) 8,194 5,073
Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents, Beginning of Period 77 326
Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents, End of Period $ 61 $ 265
v3.24.0.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Millions
Total
Common stock and paid-in capital
Retained earnings
Accumulated other comprehensive income
Balance at beginning of period at Sep. 25, 2022 $ 18,013 $ 195 $ 17,840 $ (22)
Common stock issued under employee benefit plans   38    
Repurchases and retirements of common stock   (591) (679)  
Share-based compensation   667    
Tax withholdings related to vesting of share-based payments   (309)    
Common stock issued in acquisition   0    
Net income     2,235  
Dividends     (879)  
Other comprehensive income       315
Balance at end of period at Dec. 25, 2022 $ 18,810 0 18,517 293
Dividends per share announced $ 0.75      
Balance at beginning of period at Sep. 24, 2023 $ 21,581 490 20,733 358
Common stock issued under employee benefit plans   1    
Repurchases and retirements of common stock   (773) (11)  
Share-based compensation   629    
Tax withholdings related to vesting of share-based payments   (370)    
Common stock issued in acquisition   23    
Net income     2,767  
Dividends     (924)  
Other comprehensive income       135
Balance at end of period at Dec. 24, 2023 $ 23,058 $ 0 $ 22,565 $ 493
Dividends per share announced $ 0.80      
v3.24.0.1
Basis of Presentation and Significant Accounting Policies Update
3 Months Ended
Dec. 24, 2023
Basis of Presentation [Abstract]  
Basis of Presentation and Significant Accounting Policies Update Basis of Presentation and Significant Accounting Policies Update
Financial Statement Preparation. These condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (GAAP) for interim financial information and the instructions to Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. In the opinion of management, the interim financial information includes all normal recurring adjustments necessary for a fair statement of the results for the interim periods. These condensed consolidated financial statements are unaudited and should be read in conjunction with our Annual Report on Form 10-K for our fiscal year ended September 24, 2023. Operating results for interim periods are not necessarily indicative of operating results for an entire fiscal year. We operate and report using a 52-53 week fiscal year ending on the last Sunday in September. Each of the three months ended December 24, 2023 and December 25, 2022 included 13 weeks.
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts and the disclosure of contingent amounts in our condensed consolidated financial statements and the accompanying notes. Actual results could differ from those estimates. Certain prior year amounts have been reclassified to conform to the current year presentation.
Recent Accounting Pronouncements.
Segment Reporting Disclosures: In November 2023, the Financial Accounting Standards Board (FASB) issued new requirements to disclose certain incremental segment information on an annual and interim basis, including (among other items) additional disclosure about significant segment expenses. We will adopt the new requirements for our annual periods starting in fiscal 2025 (and interim periods thereafter) on a retrospective basis.
Income Tax Disclosures: In December 2023, the FASB issued new requirements to disclose annually certain additional disaggregated income tax information related to the effective tax rate reconciliation and income taxes paid, among other items. We will adopt the new requirements starting in fiscal 2026 on a retrospective basis.
v3.24.0.1
Composition of Certain Financial Statement Items
3 Months Ended
Dec. 24, 2023
Condensed Financial Information Disclosure [Abstract]  
Composition of Certain Financial Statement Items Composition of Certain Financial Statement Items
Inventories (in millions)
December 24,
2023
September 24,
2023
Raw materials$178 $176 
Work-in-process3,941 4,096 
Finished goods2,128 2,150 
$6,247 $6,422 
Revenues. We disaggregate our revenues by segment (Note 6), by products and services (as presented on our condensed consolidated statement of operations), and for our QCT (Qualcomm CDMA Technologies) segment, by revenue stream, which is based on the industry and application in which our products are sold (as presented below). In certain cases, the determination of QCT revenues by industry and application requires the use of certain assumptions. Substantially all of QCT’s revenues consist of equipment revenues that are recognized at a point in time, and substantially all of QTL’s (Qualcomm Technology Licensing) revenues represent licensing revenues that are recognized over time and are principally from royalties generated through our licensees’ sales of mobile handsets.
QCT revenue streams were as follows (in millions):
Three Months Ended
December 24,
2023
December 25,
2022
Handsets (1)$6,687 $5,754 
Automotive (2)598 456 
IoT (internet of things) (3)
1,138 1,682 
Total QCT revenues$8,423 $7,892 
(1) Includes revenues from products sold for use in mobile handsets.
(2) Includes revenues from products sold for use in automobiles, including connectivity, digital cockpit and advanced driver assistance systems (ADAS) and automated driving (AD).
(3) Primarily includes products sold for use in the following industries and applications: consumer (including computing, voice and music and extended reality (XR)), edge networking (including mobile broadband and wireless access points) and industrial (including handhelds, retail, tracking and logistics and utilities).
Revenues recognized from performance obligations satisfied (or partially satisfied) in previous periods generally include certain QCT sales-based royalty revenues related to system software, certain amounts related to QCT customer incentives and QTL royalty revenues recognized related to devices sold in prior periods (including adjustments to prior period royalty estimates, which includes the impact of the reporting by our licensees of actual royalties due) and were as follows (in millions):
Three Months Ended
December 24,
2023
December 25,
2022
Revenues recognized from previously satisfied performance obligations$176 $199 
Unearned revenues (which are considered contract liabilities) consist primarily of certain customer contracts for which QCT received fees upfront and QTL license fees for intellectual property with continuing performance obligations. In the three months ended December 24, 2023 and December 25, 2022, we recognized revenues of $181 million and $173 million, respectively, that were recorded as unearned revenues at September 24, 2023 and September 25, 2022, respectively.
Remaining performance obligations, which are primarily included in unearned revenues (as presented on our condensed consolidated balance sheet), represent the aggregate amount of the transaction price of certain customer contracts yet to be recognized as revenues as of the end of the reporting period and exclude revenues related to (a) contracts that have an original expected duration of one year or less and (b) sales-based royalties (i.e., future royalty revenues) pursuant to our license agreements.
Concentrations. A significant portion of our revenues are concentrated with a small number of customers/licensees of our QCT and QTL segments. The comparability of customer/licensee concentrations for the interim periods presented are impacted by the timing of customer/licensee device launches and/or innovation cycles and other seasonal trends, among other fluctuations in demand. Revenues from each customer/licensee that were 10% or greater of total revenues were as follows:
Three Months Ended
December 24,
2023
December 25,
2022
Customer/licensee (x)
25 %34 %
Customer/licensee (y)
18 14 
Customer/licensee (z)14 *
Other Income, Costs and Expenses. Other income and expenses in the first quarter of fiscal 2024 and 2023 included certain restructuring amounts (primarily related to accrued severance costs) from cost reduction actions initiated in fiscal 2023.
Investment and Other Income (Expense), Net (in millions)
Three Months Ended
December 24,
2023
December 25,
2022
Interest and dividend income$149 $55 
Net gains on marketable securities
11 11 
Net gains on other investments— 
Net gains on deferred compensation plan assets
66 26 
Impairment losses on other investments(12)(14)
Other(7)(2)
$212 $76 
Discontinued Operations. For the periods presented, Veoneer’s Restraint Control Systems (RCS) business assets and liabilities are reflected as held for sale on our condensed consolidated balance sheets, and the results of operations and cash flows of Veoneer’s Non-Arriver businesses (primarily consisting of the Active Safety and RCS businesses) are presented as discontinued operations on a one quarter reporting lag (through the date of disposition by SSW Partners). Cash flows from investing and financing activities from discontinued operations reported for the periods presented were not material.
On June 1, 2023, SSW Partners completed the sale of the Active Safety business to Magna International Inc. for net cash proceeds of $1.5 billion. In December 2023, SSW Partners entered into a definitive agreement to sell the RCS business. We expect that SSW Partners will complete the sale of the RCS business within early calendar 2024, subject to certain required regulatory approvals and other closing conditions being met.
v3.24.0.1
Income Taxes
3 Months Ended
Dec. 24, 2023
Income Tax Disclosure [Abstract]  
Income Taxes Income Taxes
We estimate our annual effective income tax rate to be 7% for fiscal 2024, which is lower than the U.S. federal statutory rate, primarily due to (i) a significant portion of our income qualifying for preferential treatment as foreign-derived intangible income (FDII) at a 13% effective tax rate, which includes certain benefits from the requirement to capitalize research and development expenditures for federal income tax purposes, (ii) a benefit from our federal research and development tax credit and (iii) a benefit related to foreign currency gains on a noncurrent receivable related to our refund claim of Korean withholding tax. Our effective tax rate of 5% for the first quarter of fiscal 2024 was lower than our estimated annual effective tax rate of 7% primarily due to $79 million of net discrete tax benefits. Our effective tax rate of 4% for the first quarter of fiscal 2023 included $150 million of discrete net tax benefits. Such discrete net tax benefits primarily related to foreign currency gains on a noncurrent receivable related to our refund claim of Korean withholding tax.
Income taxes payable (recorded in other current liabilities) were $1.0 billion and $1.7 billion at December 24, 2023 and September 24, 2023, respectively. This decrease was primarily due to certain U.S. federal income tax payments made in the first quarter of fiscal 2024 that were previously postponed by the Internal Revenue Service (IRS).
v3.24.0.1
Capital Stock
3 Months Ended
Dec. 24, 2023
Equity, Attributable to Parent [Abstract]  
Capital Stock Capital Stock
Stock Repurchase Program. On October 12, 2021, we announced a $10.0 billion stock repurchase program. The stock repurchase program has no expiration date. At December 24, 2023, $4.4 billion remained authorized for repurchase under our stock repurchase program.
Shares Outstanding. Shares of common stock outstanding at December 24, 2023 were as follows (in millions):
Balance at beginning of period
1,114 
Issued10 
Repurchased(6)
Balance at end of period
1,118 
Dividends. On January 19, 2024, we announced a cash dividend of $0.80 per share on our common stock, payable on March 21, 2024 to stockholders of record as of the close of business on February 29, 2024.
Earnings Per Common Share. Basic earnings per share is computed by dividing net income by the weighted-average number of common shares outstanding during the reporting period. Diluted earnings per share is computed by dividing net income by the combination of the weighted-average number of common shares outstanding and the weighted-average number of dilutive common share equivalents, comprised of shares issuable under our share-based compensation plans, during the reporting period, using the treasury stock method. The following table provides information about the diluted earnings per share calculation (in millions):
 Three Months Ended
December 24,
2023
December 25,
2022
Dilutive common share equivalents included in diluted shares11 
Shares of common stock equivalents not included because the effect would be anti-dilutive or certain performance conditions were not satisfied at the end of the period14 
v3.24.0.1
Commitments and Contingencies
3 Months Ended
Dec. 24, 2023
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Commitments and Contingencies
Legal and Regulatory Proceedings.
Consolidated Securities Class Action Lawsuit: On January 23, 2017 and January 26, 2017, securities class action complaints were filed by purported stockholders of us in the United States District Court for the Southern District of California against us and certain of our then current and former officers and directors. The complaints alleged, among other things, that we violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, as amended, and Rule 10b-5 thereunder, by making false and misleading statements and omissions of material fact in connection with certain allegations that we are or were engaged in anticompetitive conduct. The complaints sought unspecified damages, interest, fees and costs. The court consolidated the two actions, and on July 3, 2017, the plaintiffs filed a consolidated amended complaint asserting the same basic theories of liability and requesting the same basic relief. On May 23, 2022, the plaintiffs filed a motion for class certification, and on March 20, 2023, the court issued an order granting in part and denying in part the plaintiffs’ motion for class certification. The order denied class certification on the basis of alleged misrepresentations relating to our chip-level licensing practices, but certified a class on the basis of alleged misrepresentations relating to the separate operations of QCT and QTL. Trial is scheduled to begin on October 28, 2024. We intend to continue to vigorously defend ourselves in this matter.
Consumer Class Action Lawsuits: Beginning in January 2017, a number of consumer class action complaints were filed against us in the United States District Courts for the Southern and Northern Districts of California, each on behalf of a putative class of purchasers of cellular phones and other cellular devices. The cases filed in the Southern District of California were subsequently transferred to the Northern District of California. On July 11, 2017, the plaintiffs filed a consolidated amended complaint alleging that we violated California and federal antitrust and unfair competition laws by, among other things, refusing to license standard-essential patents to our competitors, conditioning the supply of certain of our baseband chipsets on the purchaser first agreeing to license our entire patent portfolio, entering into exclusive deals with companies, including Apple Inc., and charging unreasonably high royalties that do not comply with our commitments to standard setting organizations. The complaint sought unspecified damages and disgorgement and/or restitution, as well as an order that we be enjoined from further unlawful conduct. On September 27, 2018, the court certified the class. We appealed the court’s class certification order to the United States Court of Appeals for the Ninth Circuit (Ninth Circuit). On September 29, 2021, the Ninth Circuit vacated the class certification order, ruling that the district court had failed to correctly assess the propriety of applying California law to a nationwide class, and remanded the case to the district court. On June 10, 2022, the plaintiffs filed an amended complaint, limiting the proposed class to California residents rather than a nationwide class. We filed a motion to dismiss the amended complaint, and on January 6, 2023, the court issued an order granting in part and denying in part our motion to dismiss. We subsequently filed a motion for summary judgment on the plaintiffs’ remaining claims. The court granted our motion in its entirety and, on October 5, 2023, entered final judgment in Qualcomm’s favor. On November 2, 2023, the plaintiffs filed a notice of appeal to the Ninth Circuit. We intend to continue to vigorously defend ourselves in this matter.
Beginning in November 2017, several other consumer class action complaints were filed against us in Canada (in the Supreme Court of British Columbia and the Quebec Superior Court), Israel (in the Haifa District Court) and the United Kingdom (in the Competition Appeal Tribunal), each on behalf of a putative class of purchasers of cellular phones and other cellular devices, alleging violations of certain of those countries’ competition and consumer protection laws and seeking damages. The claims in these complaints are similar to those in the U.S. consumer class action complaints described above. These matters are at various stages of litigation, and we intend to continue to vigorously defend ourselves.
ParkerVision, Inc. v. QUALCOMM Incorporated: On May 1, 2014, ParkerVision filed a complaint against us in the United States District Court for the Middle District of Florida alleging that certain of our products infringed seven ParkerVision patents. On August 21, 2014, ParkerVision amended the complaint, alleging that we infringed 11 ParkerVision patents and sought damages and injunctive and other relief. ParkerVision subsequently reduced the number of patents asserted to three. The asserted patents are now expired, and injunctive relief is no longer available. ParkerVision continues to seek damages related to the sale of many of our radio frequency (RF) products sold between 2008 and 2018. On March 23, 2022, the court entered judgment in our favor on all claims and closed the case. On April 20, 2022, ParkerVision filed a notice of appeal to the United States Court of Appeals for the Federal Circuit, and on November 6, 2023, the court held a hearing on the appeal. The court has not yet issued a ruling. We intend to continue to vigorously defend ourselves in this matter.
Arm Ltd. v. QUALCOMM Incorporated: On August 31, 2022, Arm Ltd. (ARM) filed a complaint against us in the United States District Court for the District of Delaware. Our subsidiaries Qualcomm Technologies, Inc. and NuVia, Inc. (Nuvia) are also named in the complaint. The complaint alleges that following our acquisition of Nuvia, we and Nuvia breached Nuvia’s Architecture License Agreement with ARM (the Nuvia ALA) by failing to comply with the termination obligations under the Nuvia ALA. The complaint seeks specific performance, including that we cease all use of and destroy any technology that was developed under the Nuvia ALA, including processor core technology. ARM also contends that we violated the Lanham Act through trademark infringement and false designation of origin through unauthorized use of ARM’s trademarks and seeks associated injunctive and declaratory relief. ARM further seeks exemplary or punitive damages, costs, expenses and reasonable attorney’s fees, and equitable relief addressing any infringement occurring after entry of judgment.
On September 30, 2022, we filed our Answer and Counterclaim in response to ARM’s complaint denying ARM’s claims. Our counterclaim seeks a declaratory judgment that we did not breach the Nuvia ALA or the Technology License Agreement between Nuvia and ARM and that, following the acquisition of Nuvia, our architected cores (including all further developments, iterations or instantiations of the technology we acquired from Nuvia), server System-on-Chip (SoC) and compute SoC are fully licensed under our existing Architecture License Agreement and Technology License Agreement with ARM (the ARM-Qualcomm Agreements). We further seek an order enjoining ARM from making any claim that our products are not licensed under the ARM-Qualcomm Agreements, are not ARM-compliant or that we are prohibited from using ARM’s marks in the marketing of any such products. On October 26, 2022, we filed an Amended Counterclaim seeking additional declaratory relief that certain statements ARM is making in the marketplace concerning our rights under the ARM-Qualcomm Agreements are false, and that ARM has no right to prevent us from shipping our products, which are validly licensed. Trial is scheduled to begin on September 23, 2024. We intend to continue to vigorously defend ourselves in this matter.
Contingent Losses and Other Considerations: Litigation and investigations are inherently uncertain, and we face difficulties in evaluating or estimating likely outcomes or ranges of possible loss, particularly in antitrust and trade regulation investigations. We have not recorded any accrual at December 24, 2023 for contingent losses associated with the pending matters described above based on our belief that losses, while reasonably possible, are not probable. Further, any possible amount or range of loss cannot be reasonably estimated at this time. The unfavorable resolution of one or more of these matters could have a material adverse effect on our business, results of operations, financial condition or cash flows. We are engaged in numerous other legal actions not described above (for example, our 2010 European Commission matter relating to the Icera complaint, and other matters arising in the ordinary course of our business, including those relating to employment matters or the initiation or defense of proceedings relating to intellectual property rights) and, while there can be no assurance, we believe that the ultimate outcome of these other legal actions will not have a material adverse effect on our business, results of operations, financial condition or cash flows.
v3.24.0.1
Segment Information
3 Months Ended
Dec. 24, 2023
Segment Reporting [Abstract]  
Segment Information Segment Information
We are organized on the basis of products and services and have three reportable segments. We conduct business primarily through our QCT semiconductor business and our QTL licensing business. QCT develops and supplies integrated circuits and system software based on 3G/4G/5G and other technologies, including RFFE (radio frequency front-end), for use in mobile devices; automotive systems for connectivity, digital cockpit and ADAS/AD; and IoT including consumer electronic devices; industrial devices; and edge networking products. QTL grants licenses or otherwise provides rights to use portions of our intellectual property portfolio, which includes certain patent rights essential to and/or useful in the manufacture and sale of certain wireless products. Our QSI (Qualcomm Strategic Initiatives) reportable segment makes strategic investments. We also have nonreportable segments, including QGOV (Qualcomm Government Technologies) and our cloud computing processing initiative.
The table below presents revenues and earnings (loss) before income taxes (EBT) for reportable segments (in millions):
Three Months Ended
December 24,
2023
December 25,
2022
Revenues
QCT$8,423 $7,892 
QTL1,460 1,524 
QSI13 
Reconciling items39 40 
Total$9,935 $9,463 
EBT
QCT$2,593 $2,183 
QTL1,080 1,117 
QSI11 (8)
Reconciling items(722)(921)
Total$2,962 $2,371 
Reconciling items for revenues and EBT in the previous table were as follows (in millions):
Three Months Ended
December 24,
2023
December 25,
2022
Revenues
Nonreportable segments$39 $40 
EBT
Unallocated cost of revenues$(56)$(65)
Unallocated research and development expenses(533)(522)
Unallocated selling, general and administrative expenses(185)(167)
Unallocated other income (expenses)
28 (80)
Unallocated interest expense(178)(170)
Unallocated investment and other income, net
208 87 
Nonreportable segments(6)(4)
$(722)$(921)
v3.24.0.1
Fair Value Measurements and Marketable Securities
3 Months Ended
Dec. 24, 2023
Fair Value Measurements [Abstract]  
Fair Value Measurements and Marketable Securities Fair Value Measurements and Marketable Securities
The following table presents our fair value hierarchy for assets and liabilities measured at fair value on a recurring basis at December 24, 2023 (in millions):
Level 1Level 2Level 3Total
Assets    
Cash equivalents$4,979 $1,796 $— $6,775 
Marketable securities:    
Corporate bonds and notes— 3,220 — 3,220 
U.S. Treasury securities and government-related securities220 65 — 285 
Mortgage- and asset-backed securities— 280 — 280 
Equity securities136 — — 136 
Total marketable securities356 3,565 — 3,921 
Derivative instruments— 30 — 30 
Other investments815 — 51 866 
Total assets measured at fair value$6,150 $5,391 $51 $11,592 
Liabilities    
Derivative instruments$— $205 $— $205 
Other liabilities813 — — 813 
Total liabilities measured at fair value$813 $205 $— $1,018 
Long-term Debt. At December 24, 2023, the aggregate fair value of our outstanding fixed-rate notes, based on Level 2 inputs, was approximately $15.1 billion.
Marketable Securities. At December 24, 2023 and September 24, 2023, our marketable securities were all classified as current and were primarily comprised of available-for-sale debt securities (substantially all of which were corporate bonds and notes).
The contractual maturities of available-for-sale debt securities were as follows (in millions):
December 24,
2023
Years to Maturity
Less than one year$1,820 
One to five years1,678 
Five to ten years
No single maturity date280 
Total$3,785 
Debt securities with no single maturity date included mortgage- and asset-backed securities.
v3.24.0.1
Pay vs Performance Disclosure - USD ($)
$ in Millions
3 Months Ended
Dec. 24, 2023
Dec. 25, 2022
Pay vs Performance Disclosure    
Net income $ 2,767 $ 2,235
v3.24.0.1
Insider Trading Arrangements
3 Months Ended
Dec. 24, 2023
shares
James H. Thompson [Member]  
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement
On November 29, 2023, James H. Thompson, our Chief Technology Officer, Qualcomm Technologies, Inc., adopted a Rule 10b5-1 trading arrangement (as defined in Item 408 of Regulation S-K) providing for the sale of up to 72,000 shares of our common stock through November 8, 2024.
Name James H. Thompson
Title Chief Technology Officer
Rule 10b5-1 Arrangement Adopted true
Adoption Date November 29, 2023
Arrangement Duration 345 days
Aggregate Available 72,000
Akash Palkhiwala [Member]  
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement
On December 7, 2023, Akash Palkhiwala, then our Chief Financial Officer (currently our Chief Financial Officer and Chief Operating Officer), adopted a Rule 10b5-1 trading arrangement providing for the sale of up to 40,000 shares of our common stock through February 28, 2025.
Name Akash Palkhiwala
Title Chief Financial Officer and Chief Operating Officer
Rule 10b5-1 Arrangement Adopted true
Adoption Date December 7, 2023
Arrangement Duration 449 days
Aggregate Available 40,000
v3.24.0.1
Basis of Presentation and Significant Accounting Policies Update (Policies)
3 Months Ended
Dec. 24, 2023
Basis of Presentation [Abstract]  
Fiscal Period, Policy We operate and report using a 52-53 week fiscal year ending on the last Sunday in September. Each of the three months ended December 24, 2023 and December 25, 2022 included 13 weeks.
Use of Estimates, Policy The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts and the disclosure of contingent amounts in our condensed consolidated financial statements and the accompanying notes. Actual results could differ from those estimates.
Recent Accounting Pronouncements, Policy
Segment Reporting Disclosures: In November 2023, the Financial Accounting Standards Board (FASB) issued new requirements to disclose certain incremental segment information on an annual and interim basis, including (among other items) additional disclosure about significant segment expenses. We will adopt the new requirements for our annual periods starting in fiscal 2025 (and interim periods thereafter) on a retrospective basis.
Income Tax Disclosures: In December 2023, the FASB issued new requirements to disclose annually certain additional disaggregated income tax information related to the effective tax rate reconciliation and income taxes paid, among other items. We will adopt the new requirements starting in fiscal 2026 on a retrospective basis.
Revenue Recognition, Policy We disaggregate our revenues by segment (Note 6), by products and services (as presented on our condensed consolidated statement of operations), and for our QCT (Qualcomm CDMA Technologies) segment, by revenue stream, which is based on the industry and application in which our products are sold (as presented below). In certain cases, the determination of QCT revenues by industry and application requires the use of certain assumptions. Substantially all of QCT’s revenues consist of equipment revenues that are recognized at a point in time, and substantially all of QTL’s (Qualcomm Technology Licensing) revenues represent licensing revenues that are recognized over time and are principally from royalties generated through our licensees’ sales of mobile handsets.
Earnings Per Common Share, Policy Basic earnings per share is computed by dividing net income by the weighted-average number of common shares outstanding during the reporting period. Diluted earnings per share is computed by dividing net income by the combination of the weighted-average number of common shares outstanding and the weighted-average number of dilutive common share equivalents, comprised of shares issuable under our share-based compensation plans, during the reporting period, using the treasury stock method.
Segment Reporting, Policy We are organized on the basis of products and services and have three reportable segments.
v3.24.0.1
Composition of Certain Financial Statement Items (Tables)
3 Months Ended
Dec. 24, 2023
Condensed Financial Information Disclosure [Abstract]  
Inventories
Inventories (in millions)
December 24,
2023
September 24,
2023
Raw materials$178 $176 
Work-in-process3,941 4,096 
Finished goods2,128 2,150 
$6,247 $6,422 
QCT Revenues Disaggregated
QCT revenue streams were as follows (in millions):
Three Months Ended
December 24,
2023
December 25,
2022
Handsets (1)$6,687 $5,754 
Automotive (2)598 456 
IoT (internet of things) (3)
1,138 1,682 
Total QCT revenues$8,423 $7,892 
(1) Includes revenues from products sold for use in mobile handsets.
(2) Includes revenues from products sold for use in automobiles, including connectivity, digital cockpit and advanced driver assistance systems (ADAS) and automated driving (AD).
(3) Primarily includes products sold for use in the following industries and applications: consumer (including computing, voice and music and extended reality (XR)), edge networking (including mobile broadband and wireless access points) and industrial (including handhelds, retail, tracking and logistics and utilities).
Revenue recognized from performance obligations satisfied in previous periods
Revenues recognized from performance obligations satisfied (or partially satisfied) in previous periods generally include certain QCT sales-based royalty revenues related to system software, certain amounts related to QCT customer incentives and QTL royalty revenues recognized related to devices sold in prior periods (including adjustments to prior period royalty estimates, which includes the impact of the reporting by our licensees of actual royalties due) and were as follows (in millions):
Three Months Ended
December 24,
2023
December 25,
2022
Revenues recognized from previously satisfied performance obligations$176 $199 
Customer Concentrations - Revenues Revenues from each customer/licensee that were 10% or greater of total revenues were as follows:
Three Months Ended
December 24,
2023
December 25,
2022
Customer/licensee (x)
25 %34 %
Customer/licensee (y)
18 14 
Customer/licensee (z)14 *
Investment and Other Income (Expense), Net
Investment and Other Income (Expense), Net (in millions)
Three Months Ended
December 24,
2023
December 25,
2022
Interest and dividend income$149 $55 
Net gains on marketable securities
11 11 
Net gains on other investments— 
Net gains on deferred compensation plan assets
66 26 
Impairment losses on other investments(12)(14)
Other(7)(2)
$212 $76 
v3.24.0.1
Capital Stock Earnings per Common Share (Tables)
3 Months Ended
Dec. 24, 2023
Earnings Per Share [Abstract]  
Schedule of Capital Units
Shares Outstanding. Shares of common stock outstanding at December 24, 2023 were as follows (in millions):
Balance at beginning of period
1,114 
Issued10 
Repurchased(6)
Balance at end of period
1,118 
Schedule of Earnings Per Share, Basic and Diluted The following table provides information about the diluted earnings per share calculation (in millions):
 Three Months Ended
December 24,
2023
December 25,
2022
Dilutive common share equivalents included in diluted shares11 
Shares of common stock equivalents not included because the effect would be anti-dilutive or certain performance conditions were not satisfied at the end of the period14 
v3.24.0.1
Segment Information (Tables)
3 Months Ended
Dec. 24, 2023
Segment Reporting [Abstract]  
Revenues and EBT for reportable segments
The table below presents revenues and earnings (loss) before income taxes (EBT) for reportable segments (in millions):
Three Months Ended
December 24,
2023
December 25,
2022
Revenues
QCT$8,423 $7,892 
QTL1,460 1,524 
QSI13 
Reconciling items39 40 
Total$9,935 $9,463 
EBT
QCT$2,593 $2,183 
QTL1,080 1,117 
QSI11 (8)
Reconciling items(722)(921)
Total$2,962 $2,371 
Reconciling items for reportable segments - revenues
Reconciling items for revenues and EBT in the previous table were as follows (in millions):
Three Months Ended
December 24,
2023
December 25,
2022
Revenues
Nonreportable segments$39 $40 
EBT
Unallocated cost of revenues$(56)$(65)
Unallocated research and development expenses(533)(522)
Unallocated selling, general and administrative expenses(185)(167)
Unallocated other income (expenses)
28 (80)
Unallocated interest expense(178)(170)
Unallocated investment and other income, net
208 87 
Nonreportable segments(6)(4)
$(722)$(921)
Reconciling items for reportable segments - EBT
Reconciling items for revenues and EBT in the previous table were as follows (in millions):
Three Months Ended
December 24,
2023
December 25,
2022
Revenues
Nonreportable segments$39 $40 
EBT
Unallocated cost of revenues$(56)$(65)
Unallocated research and development expenses(533)(522)
Unallocated selling, general and administrative expenses(185)(167)
Unallocated other income (expenses)
28 (80)
Unallocated interest expense(178)(170)
Unallocated investment and other income, net
208 87 
Nonreportable segments(6)(4)
$(722)$(921)
v3.24.0.1
Fair Value Measurements (Tables)
3 Months Ended
Dec. 24, 2023
Fair Value Measurements [Abstract]  
Fair value hierarchy for assets and liabilities measured at fair value on a recurring basis
The following table presents our fair value hierarchy for assets and liabilities measured at fair value on a recurring basis at December 24, 2023 (in millions):
Level 1Level 2Level 3Total
Assets    
Cash equivalents$4,979 $1,796 $— $6,775 
Marketable securities:    
Corporate bonds and notes— 3,220 — 3,220 
U.S. Treasury securities and government-related securities220 65 — 285 
Mortgage- and asset-backed securities— 280 — 280 
Equity securities136 — — 136 
Total marketable securities356 3,565 — 3,921 
Derivative instruments— 30 — 30 
Other investments815 — 51 866 
Total assets measured at fair value$6,150 $5,391 $51 $11,592 
Liabilities    
Derivative instruments$— $205 $— $205 
Other liabilities813 — — 813 
Total liabilities measured at fair value$813 $205 $— $1,018 
Investments Classified by Contractual Maturity Date
The contractual maturities of available-for-sale debt securities were as follows (in millions):
December 24,
2023
Years to Maturity
Less than one year$1,820 
One to five years1,678 
Five to ten years
No single maturity date280 
Total$3,785 
v3.24.0.1
Composition of Certain Financial Statement Items Inventories (Details) - USD ($)
$ in Millions
Dec. 24, 2023
Sep. 24, 2023
Inventory, Net [Abstract]    
Raw materials $ 178 $ 176
Work-in-process 3,941 4,096
Finished goods 2,128 2,150
Inventories $ 6,247 $ 6,422
v3.24.0.1
Composition of Certain Financial Statement Items Revenues (Details) - USD ($)
$ in Millions
3 Months Ended
Dec. 24, 2023
Dec. 25, 2022
Revenue    
Revenues $ 9,935 $ 9,463
Contract with Customer, Performance Obligation Satisfied in Previous Period 176 199
Contract with Customer, Liability, Revenue Recognized 181 173
QCT    
Revenue    
Revenues 8,423 7,892
Handsets | QCT    
Revenue    
Revenues [1] 6,687 5,754
Automotive | QCT    
Revenue    
Revenues [2] 598 456
IoT | QCT    
Revenue    
Revenues [3] $ 1,138 $ 1,682
[1] Includes revenues from products sold for use in mobile handsets.
[2] Includes revenues from products sold for use in automobiles, including connectivity, digital cockpit and advanced driver assistance systems (ADAS) and automated driving (AD).
[3] Primarily includes products sold for use in the following industries and applications: consumer (including computing, voice and music and extended reality (XR)), edge networking (including mobile broadband and wireless access points) and industrial (including handhelds, retail, tracking and logistics and utilities).
v3.24.0.1
Composition of Certain Financial Statement Items Concentrations (Details) - Sales - Customer Concentration Risk
3 Months Ended
Dec. 24, 2023
Dec. 25, 2022
Customer/licensee (x)    
Concentration Risk    
Concentration Risk, Percentage 25.00% 34.00%
Customer/licensee (y)    
Concentration Risk    
Concentration Risk, Percentage 18.00% 14.00%
Customer/licensee (z)    
Concentration Risk    
Concentration Risk, Percentage 14.00%  
v3.24.0.1
Composition of Certain Financial Statement Items Investment and Other Income (Expense), Net (Details) - USD ($)
$ in Millions
3 Months Ended
Dec. 24, 2023
Dec. 25, 2022
Investment Income, Net [Abstract]    
Interest and dividend income $ 149 $ 55
Net gains on marketable securities 11 11
Net gains on other investments 5 0
Net gains on deferred compensation plan assets 66 26
Impairment losses on other investments (12) (14)
Other (7) (2)
Investment and other income, net $ 212 $ 76
v3.24.0.1
Composition of Certain Financial Statement Items Discontinued Operations (Details)
$ in Millions
Jun. 01, 2023
USD ($)
Veoneer's Active Safety  
Discontinued Operations [Abstract]  
Disposal Group, Including Discontinued Operation, Consideration $ 1,500
v3.24.0.1
Income Taxes (Details) - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
Dec. 24, 2023
Dec. 25, 2022
Sep. 29, 2024
Sep. 24, 2023
Income Taxes        
Effective income tax rate (benefit) 5.00% 4.00%    
Income Tax Expense (Benefit) $ 151 $ 98    
Other Current Liabilities        
Income Taxes        
Accrued Income Taxes, Current 1,000     $ 1,700
Internal Revenue Service (IRS)        
Income Taxes        
Income Tax Expense (Benefit) $ 79 $ 150    
Forecast        
Income Taxes        
Effective income tax rate (benefit)     7.00%  
Forecast | FDII Effective Tax Rate        
Income Taxes        
Effective income tax rate (benefit)     13.00%  
v3.24.0.1
Capital Stock Share Repurchase Program (Details) - $10B stock repurchase program announced October 12, 2021 - USD ($)
$ in Billions
Dec. 24, 2023
Oct. 12, 2021
Stock Repurchase Program    
Authorized amount   $ 10.0
Remaining authorized amount $ 4.4  
v3.24.0.1
Capital Stock Shares Outstanding (Details)
shares in Millions
3 Months Ended
Dec. 24, 2023
shares
Shares Outstanding [Abstract]  
Balance at beginning of period 1,114
Issued 10
Repurchased (6)
Balance at end of period 1,118
v3.24.0.1
Capital Stock Dividends (Details) - $ / shares
3 Months Ended
Mar. 21, 2024
Feb. 29, 2024
Jan. 19, 2024
Dec. 24, 2023
Dec. 25, 2022
Capital Stock Dividends          
Dividends per share announced       $ 0.80 $ 0.75
Subsequent Event          
Capital Stock Dividends          
Dividends Payable, Date Declared     Jan. 19, 2024    
Dividends per share announced     $ 0.80    
Dividends Payable, Date to be Paid Mar. 21, 2024        
Dividends Payable, Date of Record   Feb. 29, 2024      
v3.24.0.1
Capital Stock Earnings per Common Share (Details) - shares
shares in Millions
3 Months Ended
Dec. 24, 2023
Dec. 25, 2022
Earnings Per Share [Abstract]    
Dilutive common share equivalents included in diluted shares 11 9
Shares of common stock equivalents not included because the effect would be anti-dilutive or certain performance conditions were not satisfied at the end of the period 14 5
v3.24.0.1
Commitments and Contingencies Legal and Regulatory Proceedings (Details)
$ in Millions
Dec. 24, 2023
USD ($)
Commitments and Contingencies Disclosure [Abstract]  
Loss Contingency, Estimate of Possible Loss $ 0
v3.24.0.1
Segment Information (Details) - USD ($)
$ in Millions
3 Months Ended
Dec. 24, 2023
Dec. 25, 2022
Segment Reporting Information [Line Items]    
Revenues $ 9,935 $ 9,463
Cost of revenues (4,312) (4,044)
Research and development expenses (2,096) (2,251)
Selling, general and administrative expenses (627) (623)
Other Operating Income (Expense), Net 28 (80)
Interest expense (178) (170)
EBT 2,962 2,371
Reconciling Items    
Segment Reporting Information [Line Items]    
Revenues 39 40
Cost of revenues (56) (65)
Research and development expenses (533) (522)
Selling, general and administrative expenses (185) (167)
Other Operating Income (Expense), Net 28 (80)
Interest expense (178) (170)
Investment and other (expense) income, net 208 87
EBT (722) (921)
QCT    
Segment Reporting Information [Line Items]    
Revenues 8,423 7,892
EBT 2,593 2,183
QTL    
Segment Reporting Information [Line Items]    
Revenues 1,460 1,524
EBT 1,080 1,117
QSI    
Segment Reporting Information [Line Items]    
Revenues 13 7
EBT 11 (8)
Other Segments    
Segment Reporting Information [Line Items]    
Revenues 39 40
Other Segments | Reconciling Items    
Segment Reporting Information [Line Items]    
EBT $ (6) $ (4)
v3.24.0.1
Fair Value Measurements Fair Value Hierarchy (Details) - Fair Value, Recurring
$ in Millions
Dec. 24, 2023
USD ($)
Assets  
Cash equivalents $ 6,775
Marketable securities 3,921
Derivative instruments 30
Other investments 866
Total assets measured at fair value 11,592
Liabilities  
Derivative instruments 205
Other liabilities 813
Total liabilities measured at fair value 1,018
Level 1  
Assets  
Cash equivalents 4,979
Marketable securities 356
Derivative instruments 0
Other investments 815
Total assets measured at fair value 6,150
Liabilities  
Derivative instruments 0
Other liabilities 813
Total liabilities measured at fair value 813
Level 2  
Assets  
Cash equivalents 1,796
Marketable securities 3,565
Derivative instruments 30
Other investments 0
Total assets measured at fair value 5,391
Liabilities  
Derivative instruments 205
Other liabilities 0
Total liabilities measured at fair value 205
Level 3  
Assets  
Cash equivalents 0
Marketable securities 0
Derivative instruments 0
Other investments 51
Total assets measured at fair value 51
Liabilities  
Derivative instruments 0
Other liabilities 0
Total liabilities measured at fair value 0
Corporate bonds and notes  
Assets  
Marketable securities 3,220
Corporate bonds and notes | Level 1  
Assets  
Marketable securities 0
Corporate bonds and notes | Level 2  
Assets  
Marketable securities 3,220
Corporate bonds and notes | Level 3  
Assets  
Marketable securities 0
U.S. Treasury and government-related Securities  
Assets  
Marketable securities 285
U.S. Treasury and government-related Securities | Level 1  
Assets  
Marketable securities 220
U.S. Treasury and government-related Securities | Level 2  
Assets  
Marketable securities 65
U.S. Treasury and government-related Securities | Level 3  
Assets  
Marketable securities 0
Mortgage- and asset-backed securities  
Assets  
Marketable securities 280
Mortgage- and asset-backed securities | Level 1  
Assets  
Marketable securities 0
Mortgage- and asset-backed securities | Level 2  
Assets  
Marketable securities 280
Mortgage- and asset-backed securities | Level 3  
Assets  
Marketable securities 0
Equity securities  
Assets  
Marketable securities 136
Equity securities | Level 1  
Assets  
Marketable securities 136
Equity securities | Level 2  
Assets  
Marketable securities 0
Equity securities | Level 3  
Assets  
Marketable securities $ 0
v3.24.0.1
Fair Value Measurements Long-term Debt (Details)
$ in Millions
Dec. 24, 2023
USD ($)
Level 2  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Long-term Debt, Fair Value $ 15,100
v3.24.0.1
Marketable Securities (Details) - Available-for-Sale Securities [Member]
$ in Millions
Dec. 24, 2023
USD ($)
Marketable Securities  
Less than one year $ 1,820
One to five years 1,678
Five to ten years 7
No single maturity date 280
Debt Securities, Available-for-sale $ 3,785